Angiogenesis Inhibitors: all 4,430 studies that test it
Page 35 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT01205022Phase 1
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube CancerCompletedNCT01204749Phase 3
- Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine TumorsStatus unknownNCT01203306Phase 2
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian CancerTerminatedNCT01202890Phase 1
- Ranibizumab for Diabetic Traction Retinal DetachmentCompletedNCT01201161Phase 2
- A Randomized Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast CancerTerminatedNCT01200212Phase 3
- Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal CancersCompletedNCT01200121Phase 2
- LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)TerminatedNCT01198054Phase 4
- Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome ResistanceCompletedNCT01197170Phase 1
- Lendexal in Patients With Primary Systemic Amyloidosis (AL) Newly DiagnosedCompletedNCT01194791Phase 2
- Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01193595Phase 1
- Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 YearsCompletedNCT01191060Phase 3
- Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast CancerCompletedNCT01190345Phase 2
- Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)Status unknownNCT01189526Phase 3
- HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular DegenerationTerminatedNCT01189019Phase 2
- Study Evaluating the Safety and Efficacy of Onartuzumab And/or Bevacizumab in Combination With Paclitaxel in Participants With Metastatic, Triple Negative Breast CancerCompletedNCT01186991Phase 2
- Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)CompletedNCT01183663Phase 1
- A Genotype-guided Study of Irinotecan Administered in Combination With 5-fluorouracil/Leucovorin (FOLFIRI) and Bevacizumab in Advanced Colorectal Cancer PatientsCompletedNCT01183494Phase 1
- Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular LymphomaWithdrawnNCT01180569Phase 1/2
- French Evaluation Group Avastin Versus LucentisCompletedNCT01170767Phase 3
- Efficacy and Safety of Sub-tenon Ranibizumab for Recurrent PterygiaCompletedNCT01169909Phase 1
- A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients With Advanced Adult T-cell Leukemia-lymphoma and Peripheral T-cell Lymphomaperipheral T-cell LymphomaCompletedNCT01169298Phase 1
- Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) DiseaseCompletedNCT01168440Phase 2
- Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma (MM) Relapsed and/or Refractory to LenalidomideCompletedNCT01166113Phase 1/2
- Lenalidomide and Cetuximab in Patients With Advanced Solid TumorsStatus unknownNCT01166035Phase 1/2
- Bevacizumab in Recurrent Grade II and III GliomaCompletedNCT01164189Phase 2
- First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal CancerCompletedNCT01163396Phase 2
- Comparison of Ranibizumab Monotherapy and Ranibizumab Combination Therapies in Recurrent or Persistent Choroidal Neovascularization Secondary to Age-related Macular DegenerationCompletedNCT01162746Phase 2
- Revlimid And Prednisone Followed By Revlimid, Melphalan And Prednisone In Multiple Myeloma PatientsCompletedNCT01160107Phase 2
- Molecular Triaging of Newly Diagnosed Breast CancerWithdrawnNCT01159236Not applicable
- Concurrent Endostar, Paclitaxel/Carboplatin and Radiotherapy for Locally Advanced Non-small Cell Lung (RT0902)Status unknownNCT01158144Phase 2
- A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)WithdrawnNCT01156961Phase 4
- Lenalidomide and Paclitaxel in Advanced Solid TumorsStatus unknownNCT01155505Phase 1
- Bendamustine and Bevacizumab for Advanced CancersCompletedNCT01152203Phase 1
- Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or GliosarcomaCompletedNCT01149850Phase 2
- A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCompletedNCT01148615Phase 1
- Avastin / Irinotecan in Patients With Recurrent or Progressive Malignant GliomaStatus unknownNCT01144988Phase 2
- A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast CancerCompletedNCT01142778Phase 2
- A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid TumorsCompletedNCT01139723Phase 1
- Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic LeukemiaCompletedNCT01133743Phase 2
- Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell LymphomaStatus unknownNCT01132989Phase 2
- Lenalidomide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid LeukemiaCompletedNCT01132586Phase 1
- Metronomic Therapy in Metastatic Breast Cancer.CompletedNCT01131195Phase 3
- RESPeCT: Revlimid Early Stage Poor Prognosis Chronic Lymphocytic Leukaemia (CLL) TrialTerminatedNCT01127542Phase 2
- Lenalidomide for Lean Body Mass and Muscle Strength in Inflammatory Cancer Cachexia SyndromeCompletedNCT01127386Phase 1/2
- LUCAS (Lucentis Compared to Avastin Study)CompletedNCT01127360Phase 4
- Lenalidomide and Cetuximab in Treating Patients With Metastatic Colorectal CancerTerminatedNCT01126450Phase 1
- Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)CompletedNCT01124253Phase 3
- Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein OcclusionStatus unknownNCT01123564Phase 2
- Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC)CompletedNCT01122615Phase 1
- Study of Lenalidomide Maintenance Versus Placebo in Responding Elderly Patients With DLBCL and Treated With R-CHOPCompletedNCT01122472Phase 3
- Paclitaxel Plus Bevacizumab for Older Patients With Breast CancerTerminatedNCT01120158Phase 2
- Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract CancerStatus unknownNCT01118039Phase 2
- Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).CompletedNCT01116219Phase 2
- Repeat-dose Study of Lenalidomide (Revlimid ®) Plus Dexamethasone in Patients With Lymphoblastic LeukemiaCompletedNCT01116193Phase 2
- Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaTerminatedNCT01116154Phase 1
- Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)Status unknownNCT01114048Phase 2
- Nab-paclitaxel, Gemcitabine, and Bevacizumab in Advanced MalignanciesCompletedNCT01113476Phase 1
- MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)CompletedNCT01112085Phase 2
- A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late RelapseCompletedNCT01111903Phase 1/2
- Bevacizumab, Chemotherapy and Valproic Acid in Advanced SarcomasCompletedNCT01106872Phase 1
- Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic RetinopathyCompletedNCT01102946Phase 2
- Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable GlioblastomaCompletedNCT01102595Phase 2
- Study of Sunitinib Before and During Radiotherapy in Newly Diagnosed Biopsy-only Glioblastoma PatientsCompletedNCT01100177Phase 2
- Lenalidomide Maintenance Post-debulking in Advanced CTCLTerminatedNCT01098656Phase 3
- Efficacy, Safety and Tolerability of Repeated Dosis of Intravitreous Bevacizumab in Uveitic Macular OedemaTerminatedNCT01095809Phase 3
- Thalidomide for Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT01094340Phase 2/3
- Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast CancerStatus unknownNCT01093235Phase 3
- Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma PatientsCompletedNCT01093196Phase 3
- Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous HemorrhageStatus unknownNCT01091896Phase 2
- Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma SubjectsCompletedNCT01091831Phase 3
- Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)CompletedNCT01091792Early Phase 1
- Safety and Efficacy of Belinostat When Used With Standard of Care Chemotherapy for Untreated Non-small Cell Lung CancerTerminatedNCT01090830Phase 1/2
- Combination of Lenalidomide and Dexamethasone in Treatment of Multiple MyelomaCompletedNCT01090089Phase 3
- Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
- Radiosurgery Plus Bevacizumab in GlioblastomaTerminatedNCT01086345Early Phase 1
- Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular SchwannomaSuspendedNCT01083966Phase 1
- Safety of Lenalidomide and Markers for Disease Progression in Patients With International Prognostic Scoring System (IPSS) Low- or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) With Isolated del5qCompletedNCT01081431Phase 2
- Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.CompletedNCT01070862Phase 3
- Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and SunitinibCompletedNCT01070706Phase 1/2
- Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
- Bevacizumab + Paclitaxel + Capecitabine in Triple Negative Metastatic Breast CancerTerminatedNCT01069796Phase 2
- Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)Status unknownNCT01069770Phase 2
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients.Status unknownNCT01067053Phase 2
- Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma PatientsCompletedNCT01063179Phase 3
- Pilot Study of Bevacizumab (Avastin) in Patients With Septic ShockWithdrawnNCT01063010Not applicable
- Dose-Ranging Study of Telintra® Tablets + Revlimid® in Patients With Non-Deletion (5q) Low to Intermediate-1 Risk Myelodysplastic Syndrome (MDS)CompletedNCT01062152Phase 1
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
- HAI Abraxane With Gemcitabine and BevacizumabCompletedNCT01057264Phase 1
- Trial of Bevacizumab and Ixabepilone for Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01057212Phase 2
- Adriamycin, Vinblastine, DTIC and Revlimid in Elderly Hodgkin Lymphoma PatientsCompletedNCT01056679Phase 1
- Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid TumorsCompletedNCT01055795Phase 1
- S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple MyelomaWithdrawnNCT01055301Phase 2
- IFM2009-02-Pomalidomide and Dexamethasone Phase 2 MyelomaCompletedNCT01053949Phase 2
- Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic SyndromeStatus unknownNCT01053806Phase 2
- OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade GliomasWithdrawnNCT01052363Phase 1
- A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung AdenocarcinomaCompletedNCT01051934Phase 1
- Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous SystemCompletedNCT01048554Phase 2
- Lenalidomide And Rituximab as Maintenance Therapy in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedNCT01045928Phase 1